Sanofi Issues $5.2 Billion Share Buyback; Expects Sales, Core …

Jan 30, 2025 · Sanofi said it plans to launch a $5.2 Bln share buyback and said it expects sales and core earnings growth in 2025 after higher fourth-quarter sales. The French pharmaceutical …

CouponFollow Extension

$5
OFF

Sanofi Issues $5.2 Billion Share Buyback; Expects Sales, Core …

2 weeks from now

Jan 30, 2025 · Sanofi said it plans to launch a $5.2 Bln share buyback and said it expects sales and core earnings growth in 2025 after higher fourth-quarter sales. The French pharmaceutical …

morningstar.com

$5.21
OFF

Sanofi Plans Share Buybacks, Signals More Deals Post Opella Sale

2 weeks from now

Jan 30, 2025 · Sanofi said on Thursday it would buy back 5 billion euros ($5.21 billion) in shares this year and could be more active with acquisitions in the near term as the drugmaker moves …

reuters.com

$5
OFF

Sanofi Expects Strong Earnings Growth This Year, Plans $5.2 Billion ...

2 weeks from now

Jan 30, 2025 · Sanofi forecast stronger earnings growth this year and said it planned to launch a $5.2 billion share buyback. The French pharmaceutical company said business earnings per …

morningstar.com

$5
OFF

Sanofi, Q4 2024 Earnings Call, Jan 30, 2025 - MarketScreener.com

2 weeks from now

Jan 30, 2025 · Sanofi Expects Strong Earnings Growth This Year, Plans $5.2 Billion Buyback -- Update ... Revenue Increases; 2025 Sales Growth Guidance Issued 05:35am: MT Sanofi: …

marketscreener.com

$5
OFF

Sanofi Issues $5.2 Billion Share Buyback; Expects Sales, Core …

2 weeks from now

Jan 30, 2025 · Sanofi said it plans to launch a $5.2 Bln share buyback and said it expects sales and core earnings growth in 2025 after higher fourth-quarter sales. The French pharmaceutical …

marketscreener.com

15%
OFF

Sanofi Expects Strong Earnings Growth This Year, Plans $5.2 Billion …

2 weeks from now

Sanofi SAN-0.15%decrease; red down pointing triangle forecast stronger earnings growth this year and said it planned to launch a $5.2 billion share buyback. The French pharmaceutical …

wsj.com

$5
OFF

Sanofi Expects Strong Earnings Growth This Year, Plans $5.2 Billion ...

2 weeks from now

Jan 30, 2025 · This is the first time Sanofi provided a sales forecast for the group to investors. Sanofi also said it would launch a buyback of up to 5 billion euros ($5.21 billion) in 2025, …

marketscreener.com

$5.21
OFF

Sanofi Forecasts Stronger Profit Growth, Announces €5 Billion Stock …

2 weeks from now

Jan 30, 2025 · Investing.com -- Sanofi (NASDAQ:SNY) announced on Thursday that it plans to repurchase €5 billion ($5.21 billion) worth of shares this year and may take a more active …

yahoo.com

$5
OFF

Sanofi Plans €5 Billion Buyback, Sees Higher Profit Growth

2 weeks from now

Jan 30, 2025 · Sanofi said it will repurchase €5 billion ($5.2 billion) of stock and grow profits faster this year as the drugmaker pivots away from consumer health to focus on fast-growing drugs …

bloomberg.com

€5
OFF

Sanofi Targets Mid To High Single-digit Sales Growth In 2025 With …

2 weeks from now

Jan 30, 2025 · Sanofi targets mid to high single-digit sales growth in 2025 with €5B share buyback plan ... A €5 billion share buyback program is planned for 2025, aiming to offset Opella dilution …

seekingalpha.com

$5
OFF

Correction To Sanofi Article - Morningstar

2 weeks from now

Jan 30, 2025 · "Sanofi Issues $5.2 Bln Share Buyback; Expects Sales, Core Earnings Growth," at 0647 GMT, incorrectly said net profit was 9.19 billion euros. (END) Dow Jones Newswires …

morningstar.com

$5.21
OFF

Sanofi Forecasts Stronger Profit Growth, Announces €5 Billion Stock …

2 weeks from now

Jan 30, 2025 · Investing.com -- Sanofi (EPA: SASY) (NASDAQ: SNY) announced on Thursday that it plans to repurchase €5 billion ($5.21 billion) worth of shares this year and may take a …

investing.com

$5.21
OFF

Sanofi's Strategic Share Buyback Amid Robust Q4 Performance

2 weeks from now

The company also revealed plans to repurchase shares worth 5 billion euros (approximately $5.21 billion) this year, bolstering investor confidence in its robust drug pipeline. Sanofi, renowned as …

indexbox.io

63%
OFF

Sanofi Reports Earnings Results For The Fourth Quarter And Full …

2 weeks from now

Jan 30, 2025 · 103.52 EUR +1.63% +3.67% +10.48%: ... Sanofi Plans EUR5 Billion Share Buyback for FY25 ... Sanofi Issues $5.2 Billion Share Buyback; Expects Sales, Core Earnings …

marketscreener.com

$100
OFF

Form 10-K - SEC.gov

2 weeks from now

Share Repurchase Program . In 2014, the Company’s board of directors approved a share repurchase program that enables the Company to purchase up to $100 million of its shares of …

sec.gov

$5
OFF

Sanofi Issues $5.2 Billion Share Buyback; Expects Sales, Core …

2 weeks from now

Jan 30, 2025 · By Helena Smolak Sanofi said it plans to launch a $5.2 Bln share buyback and said it expects sales and core earnings growth in 2025 after higher fourth-quarter sales. The …

marketscreener.com

$3.50
OFF

Bell Labs - The Idea Factory - Free Download PDF

2 weeks from now

Jul 19, 2016 · www.njtc.org May 2012 Vol. 16 Issue 4 $3.50 The Business Behind the Technology Sectors of New Jersey Innovative, Inspiring, Revolutionary… Bell Labs – The Idea Factory …

kupdf.net

$3.48
OFF

SGB 2016 Retail Top 100: The List | SGB Media Online

2 weeks from now

In late February, Founder and Chairman James W. Cabela, 76, remained the company’s largest shareholder with 23.2 percent of the company’s shares. Total 2015 Sales: $3.48 billion. Total …

sgbonline.com

10%
OFF

Lauren Cohn - JCPenney - LinkedIn

2 weeks from now

Shares fell 10%, to $15.52, in after-hours trading. ... pharmacy business weighed on third-quarter sales, and that it expects fourth-quarter same-store sales to be lower than those in the third ...

linkedin.com

FAQs about Sanofi Issues $5.2 Billion Share Buyback; Expects Sales, Core … Coupon?

Will Sanofi San buyback a $5.2 billion share?

Sanofi SAN 1.41% forecast stronger earnings growth this year and said it planned to launch a $5.2 billion share buyback. The French pharmaceutical company said business earnings per share–a key measure of profitability–should grow at a low double-digit percentage at constant currencies this year, above growth of 4.1% that Sanofi reported for 2024. ...

Will Sanofi repurchase €5 billion worth of shares this year?

Investing.com -- Sanofi (NASDAQ:SNY) announced on Thursday that it plans to repurchase €5 billion ($5.21 billion) worth of shares this year and may take a more active approach to acquisitions in the near term. The move comes as the company prepares to sell a significant stake in its consumer health business. ...

Why did Sanofi report quarterly earnings?

Sanofi, one of the world's largest makers of vaccines by sales, reported its quarterly earnings a day after Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, came under attack for his views on vaccines at a Senate confirmation hearing. ...

Is Sanofi a good stock to buy?

Jefferies analysts reiterated a Buy rating on Sanofi shares following the report. They believe the company's outlook "suggests potential consensus EPS upgrades" and added that the buyback announcement "should be taken well" by investors. ...

How did Sanofi perform in Q4 2024?

Sanofi delivered robust Q4 2024 results with strong growth across key products and new launches, including Dupixent and Beyfortus. The company’s strategic focus on R&D, pipeline productivity, and geographic expansion underpins its 2025 outlook of mid to high single-digit sales growth and low double-digit EPS growth. ...

Will Sanofi be a bit more in the near future?

We may be a bit more in the near future due to the fact that we have a strong balance sheet," said Sanofi CFO François Roger on a media call. He emphasized, however, that the company would maintain a balanced approach to potential deals. ...